人原髓細胞白血病細胞(HL-60)
產品名稱: 人原髓細胞白血病細胞(HL-60)
英文名稱: HL-60
產品編號: TCH-C204
產品價格: 0
產品產地: 蘇州
品牌商標: HyCyte™
更新時間: null
使用范圍: null
- 聯系人 :
- 地址 : 太倉市開發區
- 郵編 : 215300
- 所在區域 : 江蘇
- 電話 : 131****7797 點擊查看
- 傳真 : 點擊查看
- 郵箱 : hfx@dingbio.com
細胞名稱:人原髓細胞白血病細胞(STR鑒定正確)
細胞別稱:HL 60; HL.60; HL60

該細胞由CollinsSJ從一位患有急性早幼粒細胞性白血病的36歲白人女性的外周血中分離建立;可自發分化,或在丁酸鹽、次黃嘌呤、佛波醇肉豆蔻酸(PMA,TPA)、DMSO(1%to1.5%)、放線菌素D和視黃酸的刺激下發生分化;PMA刺激后可分泌TNF-α。該細胞具有吞噬活性和趨化反應,癌基因myc陽性,表達補體受體和FcR。
細胞名稱:人原髓細胞白血病細胞
細胞簡稱:HL-60
產品貨號:TCH-C204
種屬來源:人
組織來源:外周血
疾病特征:急性粒-單核細胞白血病
細胞形態:髓母細胞樣
生長特性:懸浮生長
培養體系:RPMI-1640+20%FBS+1%P/S
傳代比例:1:3-1:6,每2-3天換液一次
傳代周期:48-72 h
培養條件:氣相:95%空氣+5%CO2,溫度:37℃
凍存條件:60%基礎培養基+30%FBS+10%DMSO,液氮儲存
質量檢測:細菌、真菌、支原體檢測均為陰性
參考文獻:
"Gallagher R, et al. Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia. Blood 54: 713-733, 1979. PubMed: 288488
Collins SJ, et al. Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds. Proc. Natl. Acad. Sci. USA 75: 2458-2462, 1978. PubMed: 276884
Collins SJ, et al. Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture. Nature 270: 347-349, 1977. PubMed: 271272
Aggarwal BB, et al. Human tumor necrosis factor. Production, purification, and characterization. J. Biol. Chem. 260: 2345-2354, 1985. PubMed: 3871770
Nahm MH, et al. Identification of cross-reactive antibodies with low opsonophogocytic activity for Streptoccus pneumoniae. J. Infect. Dis. 176: 698-703, 1997. PubMed: 9291318
Berninghausen O, Leippe M. Necrosis versus apoptosis as the mechanism of target cell death induced by Entamoeba histolytica. Infect. Immun. 65: 3615-3621, 1997. PubMed: 9284127
Aparicio CL, et al. Correction for label leakage in fluorimetric assays of cell adhesion. BioTechniques 23: 1056-1060, 1997. PubMed: 9421636
Mansat V, et al. The protein kinase C activators phorbol esters and phosphatidylserine inhibit neutral aphingomyelinase activation, ceramide generation, and apoptosis triggered by daunorubicin. Cancer Res. 57: 5300-5304, 1997. PubMed: 9393753
Cuthbert JA, Lipsky PE. Regulation of proliferation and Ras localization in transformed cells by products of mevalonate metabolism. Cancer Res. 57: 3498-3504, 1997. PubMed: 9270019
Michael JM, et al. Resistance to radiation-induced apoptosis in Burkitts lumphoma cells is associated with defective ceramide signaling. Cancer Res. 57: 3600-3605, 1997. PubMed: 9270034
Clark RA, et al. Tenascin supports lymphocyte rolling. J. Cell Biol. 137: 755-765, 1997. PubMed: 9151679
Tiffany HL, et al. Enhanced expression of the eosinophil-derived neurotoin ribonuclease (RNS2) gene requires interaction between the promoter and intron. J. Biol. Chem. 271: 12387-12393, 1996. PubMed: 8647842
Chan YJ, et al. Synergistic interactions between overlapping binding sites for the serum response factor and ELK-1 proteins mediate both basal enhancement and phorbol ester responsiveness of primate cytomegalovirus. J. Virol. 70: 8590-8605, 1996. PubMed: 8970984
Mao M, et al. RIG-E, a human homolog of the murine Ly-6 family, is induced by retinoic acid during the differentiation of acute promyelocytic leukemia cell. Proc. Natl. Acad. Sci. USA 93: 5910-5914, 1996. PubMed: 8650192
Lepley RA, et al. Tyrosine kinase activity modulates catalysis and translocation of cellular 5-lipoxygenase. J. Biol. Chem. 271: 6179-6184, 1996. PubMed: 8626407
Chen H, et al. Octamer binding factors and their coactivator can activate the murine PU.1 (spi-1) promoter. J. Biol. Chem. 271: 15743-15752, 1996. PubMed: 8663022
U.S. Pharmacopeia USP Monographs: Technetium 99mTc Fanolesomab Injection. Rockville, MD: USP32-NF27, 2005"
